AUG 01, 2021 9:07 AM PDT

Berry Compound Reverses Parkinson's in Mice

WRITTEN BY: Annie Lennon

A naturally-occurring compound called farnesol found in berries and other fruits prevents and reverses Parkinson's-associated brain damage in mice. The study was published in Science Translational Medicine by researchers in the US and South Korea. 

Parkinson's disease occurs due to a loss of neurons in the brain that produce dopamine. This loss of neurons is thought to happen due to a build-up of PARIS, a protein that slows down the production of a protein called PGC-1alpha that shields brain cells from damaging oxygen molecules. Without PGC-1alpha, dopamine neurons die, leading to symptoms of Parkinson's disease.

In experiments, the researchers fed mice a farnesol-supplemented diet or a normal mouse diet for a week. They then gave the mice pre-formed fibrils of the protein alpha-synuclein, which mimic the effects of Parkinson's disease in the brain. In the end, they found that mice fed farnesol-rich diets performed an average of 100% better on strength and coordination tests used to detect the advancement of Parkinson's disease. 

The researchers later studied the brain tissue of mice from the two groups. In doing so, they found that those fed on farnesol had twice as many healthy dopaminergic neurons as those on the conventional mouse diet. Mice receiving supplements also had around 55% more PGC-1alpha in their brains than those on regular diets. 

The researchers later confirmed in chemical experiments that farnesol works by binding to PARIS and changing its shape to not interfere with PGC-1alpha production. 

The amount of farnesol currently consumed by people is unknown- both in natural and synthetic form. Moreover, safe doses of farnesol for humans are yet to be determined by clinical trials. This means that further research is needed before farnesol supplementation could begin to be considered for humans to prevent or reverse Parkinson's disease. 

 

Sources: Science Translational MedicinePubChemNeuroscience News

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 08, 2021
Microbiology
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
AUG 08, 2021
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
Researchers recently discovered bacteria that fed on the element manganese. Scientists also know that some bacterial pat ...
AUG 12, 2021
Immunology
Anticoagulants Target a Weak Spot in Coronavirus Variants
AUG 12, 2021
Anticoagulants Target a Weak Spot in Coronavirus Variants
Australian researchers have found a new molecular binding site on the coronavirus that causes COVID-19, a discovery that ...
AUG 12, 2021
Cancer
Promising Drug Target Identified for Deadly Ovarian Cancer
AUG 12, 2021
Promising Drug Target Identified for Deadly Ovarian Cancer
Scientists at the University of Alabama at Birmingham have identified a gene called DOT1L for its role in progressing th ...
Loading Comments...